A new federal watchdog report dings the three largest Medicare Advantage insurers for frequent prior authorization denials for long-term care hospital and inpatient rehabilitation stays. Another found that initial denials among skilled-nursing facilities were near-unanimously overturned.
The Senate Armed Services Committee rejected a provision in the annual defense policy bill that would have expanded coverage of fertility services for military members and their families, including in vitro fertilization (IVF), according to Sen. Tammy Duckworth (D-Ill.). “All my provision seeks to do is provide our troops with the same access to IVF that all Members of Congress already have. After everything...
Planned Parenthood’s Northwest affiliate is suing Alaska to challenge the state’s ban on telehealth abortion. In a lawsuit filed Thursday in Alaska state court, Planned Parenthood Great Northwest, Hawaii, Alaska, Indiana, Kentucky said the state’s requirement that patients seeking medication abortion must be seen in person violates Alaskans’ constitutional right to abortion. The organization is seeking a preliminary...
Novartis said its RNA therapy del-brax met goals of a Phase 1/2 study in facioscapulohumeral muscular dystrophy (FSHD), an inherited muscle disorder that currently has no FDA-approved medicines. Del-brax is one of three RNA therapies from Novartis’s $12 billion acquisition of Avidity Biosciences. The post Novartis RNA Med From $12B Deal Keeps Building Case to Become First Therapy for Rare Muscle Disease appeared first on MedCity News .
The DRC has improved testing capacity for Ebola, with two facilities operating in or near the epicenter. But this still may not be enough to keep up with a rapidly expanding disease.